An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Vor Bio (VOR) to Participate in Fireside Chat at JMP Securities Hematology and Oncology Summit
Positive
None.
Negative
None.
CAMBRIDGE, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the JMP Securities Hematology and Oncology Summit.
JMP Securities Hematology and Oncology Summit Fireside Chat: Tuesday, December 5, 2023 at 1:30 pm ET Location: Virtual
About Vor Bio Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
What is the latest announcement from Vor Bio (VOR)?
Vor Bio (VOR) will participate in a fireside chat and host virtual 1x1 investor meetings at the JMP Securities Hematology and Oncology Summit.
When and where will the fireside chat take place?
The fireside chat will take place on Tuesday, December 5, 2023, at 1:30 pm ET, and the location is virtual.
What is the ticker symbol for Vor Bio?
The ticker symbol for Vor Bio is VOR.
What is the JMP Securities Hematology and Oncology Summit?
The JMP Securities Hematology and Oncology Summit is a conference where Vor Bio will participate in a fireside chat and host virtual 1x1 investor meetings.
Why is Vor Bio participating in the fireside chat?
Vor Bio is participating in the fireside chat to engage with investors and discuss its developments in cell and genome engineering.
What is the significance of Vor Bio's participation in the summit?
Vor Bio's participation in the summit signifies its active involvement in the hematology and oncology space and its commitment to engaging with the investment community.
vor biopharma is pioneering engineered hematopoietic stem cells (ehscs) to dramatically change the treatment paradigm for hematological cancers. vor’s ehscs are designed to generate healthy, fully functional cells with specific advantageous modifications, for example to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from depletion but leaving tumor cells vulnerable. vor’s platform could potentially be used to change the treatment paradigm of both hematopoietic stem cell transplants and antigen-targeted therapies such as antibody drug conjugates, bispecific antibodies and car-t cell treatments. a proof-of-concept study for vor’s lead program has been published in proceedings of the national academy of sciences. vor is based in cambridge, mass. and has a broad intellectual property base including in-licenses from columbia university, where foundational work was conducted by inventor and vor scientific board chair siddhar
